August 4, 2010 (FinancialWire) (Investrend Information Syndicate) Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — Positioned to exploit a $1.5 billion industry, LightPath Technologies, Inc. (LPTH) Is presenting the company’s expanded glass catalog, August 3rd Through 5th at the SPIE Optics & Photonics Conference in San Diego.

Last year, the growing biomedical instrumentation and data storage laser markets had a combined estimated value of nearly $1.5 billion. LightPath Technologies. Inc., founded in 1985, with its multi-faceted operations and diverse spectrum of products, has staked-out strongholds within both of those markets. And LightPath continues to move forward claiming new territory across multiple markets with cutting-edge products.

From August 3rd through August 5th at the SPIE Optics & Photonics exhibition being held at the San Diego Convention Center, Booth 428, LightPath is showcasing its Blue Laser family of lenses, particularly those lenses optimized for use in the UV and Blue wavelength ranges. Target applications for those optics include biomedical instrumentation such as flow cytometers for cell counting, microscopes, and fluorescence spectroscopy equipment for biomedical research.

Photo-optical industry specifications for such lenses are shifting wavelengths from 650nm/780nm to 405nm. Use of the shorter wavelengths allows for higher resolution and denser storage capability. LightPath's Blue Laser family of lenses meets those specifications, and is being well received in those markets. In fact, LightPath already unveiled the new line of lenses in June, in-tandem with their European distributor, AMS Technologies, at the OPTATEC Trade Fair in Frankfurt, Germany.

LightPath's CEO Jim Gaynor commented, "LightPath Technologies is excited about the opportunity to highlight our technical advances at this conference. Molding aspheric lenses is a strategic technology and educating optical designers about the latest developments enables the development of high performance industrial tooling and biomedical optics."

Information about the SPIE Optics & Photonics Conference can be found on the web (at http://spie.org/optics-photonics.xml).

Other FinancialWire(tm) news about LightPath is accessible via The FinancialWire(tm) search function (at http://www.financialwire.net/?s=lpthnas), additional information and independent research on LightPath is available via Investrend Syndications (at http://www.investrend.com/synd0003), and official information and company filings from LightPath are accessible via the SEC website (at http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001366669).

Equity research on any public company is available through the Shareholders Research Alliance (go to http://www.investrend.com/synd0004 for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html).  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[ssryrsyr] [pltfrm] [lpthnas] [synd0003] [bsdarrgnmnt] [grdnstscrts] [ndstrls] [mnfctrng] [ndstrlspplssrvcs] [tchnlgy] [advnctchnlgy] [biomedphrm] [ftrdnwswnd] [cnfrncvntprsntn] [prsnttnsntt]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.